Protection against cellular stress by 25-hydroxyvitamin D3in breast epithelial cells

Journal of Cellular Biochemistry

Volumn 110, Issue 6, 2010, Pages 1324-1333

  Peng, Xinjian ^a   Vaishnav, Avani ^a   Murillo, Genoveva ^a   Alimirah, Fatouma ^a   Torres, Karen E O ^a   Mehta, Rajendra G ^a  

^a IIT RESEARCH INSTITUTE   (United States)

Author keywords

25(OH)D3; Breast epithelial cells; Cellular stress

Indexed keywords

ANTINEOPLASTIC AGENT; CALCIFEDIOL; CYCLINE; MICRORNA; PROTEIN P53;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CELL STRESS; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERUM; STARVATION;

APOPTOSIS; BLOTTING, WESTERN; BREAST; CALCIFEDIOL; CELL HYPOXIA; CELL LINE; CELL LINE, TUMOR; CULTURE MEDIA; CULTURE MEDIA, SERUM-FREE; CYSTEINE PROTEINASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; FEMALE; HUMANS; HYDROGEN PEROXIDE; LEUPEPTINS; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDANTS; OXIDATIVE STRESS; PROLIFERATING CELL NUCLEAR ANTIGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEIN P53; VITAMINS;

EID: 77955496828     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22646     Document Type: Article

References (51)

1. Ainsleigh HG. 1993. Beneficial effects of sun exposure on cancer mortality. Prev Med 22:132-140.
2. Chan JA, Krichevsky AM, Kosik KS. 2005. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65:6029-6033.
3. Chatterjee M. 2001. Vitamin D and genomic stability. Mutation Res 475:69-88.
4. Cross HS, Kallay E, Farhan H, Weiland T, Manhardt T. 2003. Regulation of extrarenal vitamin D metabolism as a tool for colon and prostate cancer prevention. Recent Results Cancer Res 164:413-425.
5. Cross HS, Kallay E, Lechner D, Gerdenitsch W, Adlercreutz H, Armbrecht HJ. 2004. Phytoestrogens and vitamin D metabolism: A new concept for the prevention and therapy of colorectal, prostate, and mammary carcinomas. J Nutr 134:1207S-1212S.
6. Davis C, Ross SA. 2008. Evidence for dietary regulation of microRNA in cancer cells. Nutr Rev 66:477-482.
7. Diker-Cohen T, Koren R, Ravid A. 2006. Programmed cell death of stressed keratinocytes and its inhibition by vitamin D: The role of death and survival signaling pathways. Apoptosis 11:519-534.
8. Friedrich M, Rafi L, Mitschele T, Tilgen W, Schmidt W, Reichrath J. 2003. Analysis of the vitamin D system in cervical carcinomas, breast cancer and ovarian cancer. Recent Results Cancer Res 164:239-246.
9. Garland FC, Garland CF, Gorham ED, Young JF. 1990. Geographic variation in breast cancer mortality in the United States: A hypothesis involving exposure to solar radiation. Prev Med 19:614-622.
10. Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, Chen C, Ambros VR, Israel MA. 2007. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res 67:2456-2468.
11. Gorham ED, Garland FC, Garland CF. 1990. Sunlight and breast cancer incidence in the USSR. Int J Epidemiol 19:820-824.
12. Grant WB, Garland CF. 2004. A critical review of studies on vitamin D in relation to colorectal cancer. Nutr Cancer 48:115-123.
13. Guttilla IK, White BA. 2009. Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem 284:23204-23216.
14. Hanada K, Sawamura D, Nakano H, Hashimoto I. 1995. Possible role of 1,25-dihydroxyvitamin D3-induced metallothionein in photoprotection against UVB injury in mouse skin and cultured rat keratinocytes. J Dermatol Sci 9:203-208.
15. Hiroi M, Mori K, Sakaeda Y, Shimada J, Ohmori Y. 2009. STAT1 represses hypoxia-inducible factor-1-mediated transcription. Biochem Biophys Res Commun 387:806-810.
16. Holt SK, Kwon EM, Peters U, Ostrander EA, Stanford JL. 2009. Vitamin D pathway gene variants and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 18:1929-1933.
17. Hussain-Hakimjee EA, Peng X, Mehta RR, Mehta RG. 2006. Growth inhibition of carcinogen-transformed MCF-12F breast epithelial cells and hormone-sensitive BT-474 breast cancer cells by 1alpha-hydroxyvitamin D5. Carcinogenesis 27:551-559.
18. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Menard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM. 2005. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65:7065-7070.
19. Jagtap S, Meganathan K, Wagh V, Winkler J, Hescheler J, Sachinidis A. 2009. Chemoprotective mechanism of the natural compounds, epigallocatechin-3-O- gallate, quercetin and curcumin against cancer and cardiovascular diseases. Curr Med Chem 16:1451-1462.
20. Kallay E, Bareis P, Bajna E, Kriwanek S, Bonner E, Toyokuni S, Cross HS. 2002. Vitamin D receptor activity and prevention of colonic hyperproliferation and oxidative stress. Food Chem Toxicol 40:1191-1196.
21. Klaunig JE, Kamendulis LM, Hocevar BA. 2010. Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol 38:96-109.
22. Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, Agosto-Perez FJ, Davuluri R, Liu CG, Croce CM, Negrini M, Calin GA, Ivan M. 2007. A microRNA signature of hypoxia. Mol Cell Biol 27:1859-1867.
23. Levine AJ. 2006. p53, the cellular gatekeeper for growth and division. Cell 88:323-331.
24. Li G, Luna C, Qiu J, Epstein DL, Gonzalez P. 2009. Alterations in microRNA expression in stress-induced cellular senescence. Mech Ageing Dev 130:731-741.
25. Lipkin M, Newmark HL. 1999. Vitamin D, calcium and prevention of breast cancer: A review. J Am Coll Nutr 8:392S-397S.
26. Lou YR, Laaksi I, Syvala H, Blauer M, Tammela TL, Ylikomi T, Tuohimaa P. 2004. 25-Hydroxyvitamin D3 is an active hormone in human primary prostatic stromal cells. FASEB J 18:332-344.
27. Lou YR, Molnár F, Peräkylä M, Qiao S, Kalueff AV, St-Arnaud R, Carlberg C, Tuohimaa P. 2010. 25-Hydroxyvitamin D3 is an agonistic vitamin D receptor ligand. J Steroid Biochem Mol Biol 118:162-170.
28. Lowe LC, Guy M, Mansi JL, Peckitt C, Bliss J, Wilson RG, Colston KW. 2005. Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer 41:1164-1169.
29. Mahajan A, Stahl CH. 2009. Dihydroxy-cholecalciferol stimulates adipocytic differentiation of porcine mesenchymal stem cells. J Nutr Biochem 20:512-520.
30. Marchionatti AM, Picotto G, Narvaez CJ, Welsh J, Tolosa de Talamoni NG. 2009. Antiproliferative action of menadione and 1,25(OH)2D3 on breast cancer cells. J Steroid Biochem Mol Biol 113:227-232.
31. McCarthy K, Laban C, Bustin SA, Ogunkolade W, Khalaf S, Carpenter R, Jenkins PJ. 2009. Expression of 25-hydroxyvitamin D-1-alpha-hydroxylase, and vitamin D receptor mRNA in normal and malignant breast tissue. Anticancer Res 29:155-157.
32. Mehta RR, Bratescu L, Graves J, Green A, Mehta RG. 2000. Differentiation of human breast carcinoma cells by a novel Vitamin D analog: 1alpha-hydroxyVitamin D5. Int J Oncol 16:65-73.
33. Moselhy SS, Al Mslmani MA. 2008. Chemopreventive effect of lycopene alone or with melatonin against genesis of oxidative stress and mammary tumors induced by 7,12 dimethylbenz(a)anthracene in Sprague Dawley female rats. Mol Cell Biochem 319:175-180.
34. Murillo G, Matusiak D, Benya RV, Mehta RG. 2007. Chemopreventive efficacy of 25-hydroxyvitamin D3 in colon cancer. J Steroid Biochem Mol Biol 103:763-767.
35. Peng X, Mehta RG. 2007. Differential expression of prohibitin is correlated with dual action of Vitamin D as a proliferative and antiproliferative hormone in breast epithelial cells. J Steroid Biochem Mol Biol 103:446-450.
36. Peng X, Maruo T, Matsuo H, Takekida S, Deguchi J. 1998. Serum deprivationinduced apoptosis in cultured porcine granulosa cells is characterized by increased expression of p53 protein, Fas antigen and Fas ligand and by decreased expression of PCNA. Endocr J 45:247-253.
37. Peng X, Mehta R, Wang S, Chellappan S, Mehta RG. 2006. Prohibitin is a novel target gene of vitamin D involved in its antiproliferative action in breast cancer cells. Cancer Res 66:7361-7369.
38. Peng X, Hawthorne M, Vaishnav A, St-Arnaud R, Mehta RG. 2009. 25-Hydroxyvitamin D3 is a natural chemopreventive agent against carcinogen induced precancerous lesions in mouse mammary gland organ culture. Breast Cancer Res Treat 113:31-41.
39. Riachy R, Vandewalle B, Moerman E, Belaich S, Lukowiak B, Gmyr V, Muharram G, Conte JK, Pattou F. 2005. 1,25-dihydroxyvitamin D3 protects human pancreatic islets against cytokine-induced apoptosis via down-regulation of the fas receptor. Apoptosis 11:151-159.
40. Sarver AL, French AJ, Borralho PM, Thayanithy V, Oberg AL, Silverstein KA, Morlan BW, Riska SM, Boardman LA, Cunningham JM, Subramanian S, Wang L, Smyrk TC, Rodrigues CM, Thibodeau SN, Steer CJ. 2009. Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer 9:401.
41. Schaefer A, Jung M, Mollenkopf HJ, Wagner I, Stephan C, Jentzmik F, Miller K, Lein M, Kristiansen G, Jung K. 2010. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int J Cancer 126:1166-1176.
42. Schilli MB, Paus R, Menrad A. 1998. Reduction of intrafollicular apoptosis in chemotherapy-induced alopecia by topical calcitriol-analogs. J Invest Dermatol 111:598-604.
43. Swami S, Krishnan AV, Peehl DM, Feldman D. 2005. Genistein potentiates the growth inhibitory effects of 1,25-dihydroxyvitamin D3 in DU145 human prostate cancer cells: Role of the direct inhibition of CYP24 enzyme activity. Mol Cell Endocrinol 241:49-61.
44. Toyokuni S. 2006. Novel aspects of oxidative stress-associated carcinogenesis. Antioxid Redox Signal 8:1373-1377.
45. Tran N, McLean T, Zhang X, Zhao CJ, Thomson JM, O'brien C, Rose B. 2007. MicroRNA expression profiles in head and neck cancer cell lines. Biochem Biophys Res Commun 358:12-17.
46. Tricoli JV, Jacobson JW. 2007. MicroRNA: Potential for cancer detection, diagnosis, and prognosis. Cancer Res 67:4553-4555.
47. Yoo YB, Lee KR, Kim SW, Kwon K, Goo TW, Kwon OY. 2008. Deferoxamine induces endoplasmic reticulum stress in PC12 cells. Z Naturforsch C 63:308-310.
48. Zhang X, Li P, Bao J, Nicosia SV, Wang H, Enkemann SA, Bai W. 2005. Suppression of death receptor-mediated apoptosis by 1,25-dihydroxyvitamin D3 revealed by microarray analysis. J Biol Chem 280:33458-33468.
49. Zhong Y, Armbrecht HJ, Christakos S. 2009. Calcitonin, a regulator of the 25-hydroxyvitamin D3 1alpha-hydroxylase gene. J Biol Chem284:11059-11069.
50. Zhu S, Si ML, Wu H, Mo YY. 2007. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282:14328-14336.
51. Zinser GM, Welsh J. 2004. Accelerated mammary gland development during pregnancy and delayed postlactational involution in vitamin D3 receptor null mice. Mol Endocrinol 18:2208-2223.